629 related articles for article (PubMed ID: 19132785)
21. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
23. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
Katano K; Kawano M; Koni I; Sugai S; Muro Y
J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
[TBL] [Abstract][Full Text] [Related]
25. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
[TBL] [Abstract][Full Text] [Related]
26. The presence of anti-Fc gamma receptor autoantibodies is related to the clinical presentation of primary Sjögren's syndrome.
Lamour A; Le Corre R; Pennec YL; Youinou P
J Rheumatol; 1995 Dec; 22(12):2241-5. PubMed ID: 8835556
[TBL] [Abstract][Full Text] [Related]
27. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
[TBL] [Abstract][Full Text] [Related]
28. The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors?
López-Longo FJ; Sánchez-Ramón S; Carreño L
Drug News Perspect; 2009 Nov; 22(9):543-8. PubMed ID: 20072731
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
Chung JK; Kim MK; Wee WR
Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
[TBL] [Abstract][Full Text] [Related]
30. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
Tishler M; Yaron I; Shirazi I; Yaron M
J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252
[TBL] [Abstract][Full Text] [Related]
31. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
Tishler M; Moutsopoulos HM; Yaron M
J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
[TBL] [Abstract][Full Text] [Related]
32. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
33. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
[TBL] [Abstract][Full Text] [Related]
34. Similarities and differences between primary and secondary Sjögren's syndrome.
Hernández-Molina G; Avila-Casado C; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín V; Soto-Abraham V; Recillas-Gispert C; Sánchez-Guerrero J
J Rheumatol; 2010 Apr; 37(4):800-8. PubMed ID: 20194453
[TBL] [Abstract][Full Text] [Related]
35. Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome.
Mariette X; Sibilia J; Delaforge C; Bengoufa D; Brouet JC; Soussi T
J Rheumatol; 1999 Aug; 26(8):1672-5. PubMed ID: 10451060
[TBL] [Abstract][Full Text] [Related]
36. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
Verpoort KN; Jol-van der Zijde CM; Papendrecht-van der Voort EA; Ioan-Facsinay A; Drijfhout JW; van Tol MJ; Breedveld FC; Huizinga TW; Toes RE
Arthritis Rheum; 2006 Dec; 54(12):3799-808. PubMed ID: 17133560
[TBL] [Abstract][Full Text] [Related]
37. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
38. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
39. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
[TBL] [Abstract][Full Text] [Related]
40. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
ter Borg EJ; Kelder JC
Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
